Provider Regulation, B.C. Reg. 222/2014

Section 1

Definitions

Cite as Provider Regulation, B.C. Reg. 222/2014, s. 1 · last amended April 1, 2026 · read from BC Laws on November 17, 2026

The text

In this regulation: “Act” means the Pharmaceutical Services Act; “applicant” means an applicant for enrolment as a provider; “billing privileges” means the privilege of seeking payment for the provision to another person of drugs, devices, substances or related services directly from (a) the minister, whether the privilege is granted under the Act or further to a policy made in relation to the Continuing Care Act, the Pharmacy Operations and Drug Scheduling Act or the Pharmacists, Pharmacy Operations and Drug Scheduling Act, or (b) in the case of a public drug insurance program, the public insurer through which the program is delivered; “class” means a class of provider established by the minister under section 11 (4) (b) [enrolment of providers] of the Act, those classes being the following: (a) pharmacy provider, which includes the sub-classes of Plan B provider and opioid agonist treatment provider; (b) device provider, which includes the sub-classes of compression garment provider, limb prosthesis provider, breast prosthesis provider, ocular prosthesis provider, orthosis provider and any other sub-classes established by the minister; “Community Pharmacy Standards of Practice” means Schedule F of the bylaws of the regulator of pharmacists, made under the Health Professions and Occupations Act; “extrajurisdictional applicant” or “extrajurisdictional provider” means an applicant or a provider, as applicable, having as the subject of the person's application or enrolment a site outside British Columbia but inside Canada; “First Nations Health Authority” means the First Nations Health Authority, a society under the Societies Act; “FNHB program” means the First Nations Health Benefits Program delivered through the First Nations Health Authority for the purpose of providing, to First Nations individuals who are residents of British Columbia, financial assistance for health-related goods and services; “governing body” means the following, as applicable: (a) the regulator of pharmacists; (b) an extrajurisdictional regulator within the meaning of the Health Professions and Occupations Act that is responsible for governing the health profession of pharmacy; “identity number” means the identity number referred to in section 15 [identity numbers] of the Act; “information or billing contravention” means a contravention of any of the following: (a) a provision of a pharmacy enactment or a requirement of a public drug insurance program in relation to (i) the provision of false, incomplete or misleading information, (ii) a failure to provide required information, (iii) the interference with or obstruction of a person who is exercising a power or performing a duty, or a person acting under the order or direction of that person, or (iv) a matter that resulted in the suspension or cancellation of billing privileges; (b) a provision of an enactment of another jurisdiction of Canada that is equivalent to a pharmacy enactment, in relation to any of the matters set out in paragraph (a); (c) a provision of a pharmacy enactment, the E-Health (Personal Health Information Access and Protection of Privacy) Act, the Freedom of Information and Protection of Privacy Act, the Health Professions Act, Health Professions and Occupations Act, the Personal Information Protection Act or a regulation made under any of them, in relation to the collection, use or disclosure of personal information; “NIHB program” means the Non-Insured Health Benefits Program delivered through Health Canada for the purpose of providing, to First Nations and Inuit individuals, financial assistance for health-related goods and services; “opioid agonist treatment services” means services provided by a pharmacist described in section 3 (4) [enrolment of pharmacy providers] in relation to the dispensing of a drug for opioid agonist treatment; “owner”, in respect of (a) a corporation and if applicable in the context, includes (i) in the case of a corporation that is traded publicly, the officers and directors of the corporation, and (ii) in the case of a corporation that is not traded publicly, (A) the officers, directors and shareholders of the corporation, and (B) if a subsidiary corporation, the officers, directors and shareholders of the parent corporation, and (b) a partnership and if applicable in the context, includes the partners of the partnership; “partner” and “partnership” have the same meaning as in the Partnership Act; “Pharmacists, Pharmacy Operations and Drug Scheduling Act” means the Pharmacists, Pharmacy Operations and Drug Scheduling Act before it was amended by the Pharmacy Operations and Drug Scheduling Act, S.B.C. 2003, c. 77; “pharmacy enactment” means the Act, the Continuing Care Act, the Medicare Protection Act, the Pharmacy Operations and Drug Scheduling Act, the Pharmacists, Pharmacy Operations and Drug Scheduling Act or a regulation made under any of them; “pharmacy licence” means a community pharmacy licence or a hospital pharmacy licence issued in respect of a pharmacy under the Pharmacy Operations and Drug Scheduling Act; “Plan B” means the drug plan known as Plan B, as established under section 35 of the Drug Plans Regulation; “public drug insurance program” means any of the following: (a) the FNHB program; (b) the NIHB program; (c) a public health insurance scheme delivered through a provincial or territorial government of Canada, other than the government of British Columbia, that provides to individuals financial assistance in respect of drugs, devices, substances or related services; “public insurer” means any of the following: (a) the First Nations Health Authority; (b) the government of Canada; (c) a provincial or territorial government of Canada; “regulator of medical practitioners” means the regulator that is responsible, under the Health Professions and Occupations Act, for governing the designated health profession of medicine; “regulator of pharmacists” means the regulator that is responsible, under the Health Professions and Occupations Act, for governing the designated health profession of pharmacy; “site” means (a) a pharmacy, (b) a site at which a person is authorized under an enactment of a province or territory, other than British Columbia, to store drugs or substances, or to dispense or sell drugs or substances to the public, or (c) a site through which devices are provided; “site identification code” means a unique code issued by the minister in respect of a specific site.
Read the Provider Regulation on BC Laws ↗

Made under Pharmaceutical Services Act, SBC 2012, c. 22.